As of Apr 29
| -0.30 / -1.25%|
The 7 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 30.00, with a high estimate of 36.00 and a low estimate of 22.00. The median estimate represents a +26.90% increase from the last price of 23.64.
The current consensus among 7 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.